iv
Analysis of speciated volatile nitrosamines in pharmaceuticals by GC-TEA
In the pharmaceutical industry, ensuring medication safety is paramount, especially given the potential risks posed by nitrosamine contamination. Nitrosamines, such as N-Nitrosodimethylamine (NDMA), are known carcinogens that can form under certain conditions during drug manufacturing. To tackle this issue, the 800 series Thermal Energy Analyser (TEA) by Ellutia offers an advanced solution for the precise analysis of volatile nitrosamines using gas chromatography coupled with thermal energy analysis (GC-TEA).
Nitrosamines are typically created when an amine (commonly a secondary amine) reacts with nitrosating agents like nitrites. This reaction can occur under acidic conditions or high temperatures during the manufacturing process. The detection and quantification of these contaminants are critical, as exemplified by the case of Ranitidine - once a popular antacid medication - where NDMA was found to form over time under normal storage conditions.
According to EU Regulation (EC) No 726/2004, which lists permissible limits for 27 nitrosamines, pharmaceutical companies are required to conduct risk assessments and regular testing for nitrosamines in their products. This ensures that all medications meet safety standards before reaching consumers.
The GC-TEA system by Ellutia operates by separating the nitrosamines in the GC. They are then eluted into the Pyrolyser, which breaks down the nitrosamines to release nitric oxide (NO). This NO is detected by the TEA after reacting with ozone, allowing for precise quantification of the nitrosamines present.
In practical terms, pharmaceutical samples are prepared through a method involving methanol extraction, centrifugation, and filtration before being analysed by the GC-TEA. This preparation is critical for achieving accurate and reliable results. Ellutia’s TEA is particularly noted for its sensitivity and specificity in reducing background noise and interference, which are common challenges in nitrosamine detection.
The integration of the GC-TEA system into pharmaceutical testing protocols offers a robust tool for ensuring compliance with safety regulations and protecting public health. By providing detailed and reliable methods for analysing volatile nitrosamines, Ellutia supports the pharmaceutical industry’s commitment to safety and efficacy in drug manufacturing.
Interested in learning more about Volatile Nitrosamine analysis by GC-TEA including Metformin analysis, join Ellutia’s webinar on 22nd May where their experts will be discussing the above and much more.
More information online:
ilmt.co/PL/jM3J and
ilmt.co/PL/NAEA 62508pr@reply-direct.com
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84 |
Page 85 |
Page 86 |
Page 87 |
Page 88 |
Page 89 |
Page 90 |
Page 91 |
Page 92 |
Page 93 |
Page 94
